Cardiac injury is common among hospitalised patients with COVID-19, and is associated with a higher risk of in-hospital mortality, a study from Wuhan, China, has shown. Although the exact mechanism of cardiac injury has not been defined, the researchers say it highlights the need to consider this complication in COVID-19 management.
The findings were published in JAMA: Cardiology, in which authors Shaobo Shi (Renmin Hospital of Wuhan University, Wuhan, China) et al write: The present study demonstrates the statistically significant association between cardiac injury and mortality in patients with COVID-19. Cardiac injury, as a common complication (19.7%), was associated with an unexpected high risk of mortality during hospitalisation.
The retrospective cohort study sought to explore the association between cardiac injury and mortality in patients with COVID-19. The researchers assessed consecutive patients admitted to Renmin Hospital with laboratory-confirmed COVID-19 from 20 January to 10 February 2020; the final date of follow-up was 15 February, 2020. Renmin Hospital was assigned responsibility for the treatment of patients with severe COVID-19 by the Wuhan government. Cases without cardiac biomarkers, including values of high-sensitivity troponin I (hs-TNI) and creatinine kinasemyocardial band (CK-MB), were excluded.
Clinical laboratory, radiological, and treatment data were collected and analysed. The clinical outcomes of discharge, mortality, and length of stay were monitored until the final date of follow-up, and compared between those with and without cardiac injury, with analysis of the association between cardiac injury and mortality. Cardiac injury was defined as blood levels of cardiac biomarkers (hs-TNI) above the 99th-percentile upper reference limit, regardless of new abnormalities in electrocardiography and echocardiography. Acute respiratory distress syndrome (ARDS) was defined according to the Berlin definition. Acute kidney injury was identified according to the Kidney Disease: Improving Global Outcomes definition.
The final analysis included 416 hospitalised patients with COVID-19; median age was 64 years (range, 2195 years), and 211 (50.7%) were female. Common symptoms included fever (n=334, 80.3%), cough (n=144, 34.6%), and shortness of breath (n=117, 28.1%).
A total of 82 patients (19.7%) had cardiac injury, and compared with patients without cardiac injury, these patients were older (median age 74 [range 3495] vs. 60 [range 2190] years, p<0.001). They also had more comorbidities (for example, hypertension 59.8% vs. 23.4%, p<0.001), higher leucocyte counts, and higher levels of C-reactive protein and procalcitonin. Those with cardiac injury also had higher levels of creatinine kinasemyocardial band (median 3.2, interquartile range [IQR] 1.86.2 v.s 0.9, IQR 0.61.3ng/mL), myohaemoglobin (median 128, IQR 68305 vs. 39, IQR 2765g/L), high-sensitivity troponin I (median 0.19, IQR 0.081.12 vs. <0.001) and invasive mechanical ventilation (22.0% vs. 4.2%, p<0.001) than those without cardiac injury. Complications were more common in patients with cardiac injury than those without cardiac injury, and included acute respiratory distress syndrome (58.5% vs. 14.7%, p<0.001), acute kidney injury (8.5% vs. 0.3%, p<0.001), electrolyte disturbances (15.9% vs. 5.1%, p=0.003), hypoproteinaemia (13.4% vs. 4.8%, p=0.01), and coagulation disorders (7.3% vs. 1.8%, p=0.02).
Patients with cardiac injury had shorter durations from symptom onset to follow-up compared to those without cardiac injury (mean 15.6, range 137 days vs. mean 16.9, range 337 days, p=0.001) and admission to follow-up (6.3, range 116 days vs. 7.8, range 123 days, p=0.039).
Patients with cardiac injury had higher mortality than those without cardiac injury (42 of 82, 51.2% vs. 15 of 334, 4.5%, p<0.001). The mortality rate increased in association with the magnitude of the reference value of hs-TNI. After adjusting for age, preexisting cardiovascular diseases (hypertension, coronary heart disease, and chronic heart failure), cerebrovascular diseases, diabetes mellitus, chronic obstructive pulmonary disease, renal failure, cancer, ARDS, creatinine levels greater than 133 mol/L, and NT-proBNP levels greater than 900pg/mL, the multivariable adjusted Cox proportional hazard regression model showed a significantly higher risk of death in patients with cardiac injury than in those without cardiac injury, either during time from symptom onset (hazard ratio [HR] 4.26, 95% confidence interval [CI] 1.929.49) or time from admission to study end point (HR 3.41, 95% CI 1.627.16). Under this hazard regression model, ARDS was another independent risk factor for mortality with COVID-19.
The authors point out: The present study lacks evidence from magnetic resonance imaging or echocardiography to determine the features of myocardial injury. On the basis of the present results of hs-TNI and ECG findings in a subset of patients, we can only estimate the severity of cardiac injury. Thus, because of the current limited evidence, the question of whether the SARS-CoV-2 virus can directly injure the heart requires further demonstration.
Shi and colleagues hypothesise that an intense inflammatory response superimposed on preexisting cardiovascular disease may precipitate cardiac injury in patients with COVID-19 infections, and note: Approximately 30% and 60% of patients with cardiac injury in the present study had a history of coronary heart disease and hypertension, respectively, which were significantly more prevalent than in those without cardiac injury.
Read more:
Cardiac injury in COVID-19 patients linked with higher death rate - Cardiac Rhythm News
- Frequency of Cardiac Rhythm Abnormalities in a Half ... - July 11th, 2018 [July 11th, 2018]
- Heart Arrhythmia - Arizona Heart Rhythm Center - November 20th, 2018 [November 20th, 2018]
- Cardiac Abnormalities Associated With Charcot-Marie-Tooth ... - December 8th, 2018 [December 8th, 2018]
- Troponin - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Heart - Wikipedia - December 20th, 2018 [December 20th, 2018]
- Implantable Cardiac Defibrillators (Implantable ... - January 23rd, 2019 [January 23rd, 2019]
- Cardiac Rhythm - Coverage | Medtronic - January 23rd, 2019 [January 23rd, 2019]
- Overview of Abnormal Heart Rhythms - Heart and Blood ... - March 2nd, 2019 [March 2nd, 2019]
- Inherited Heart Rhythm Clinic | LHSC - March 8th, 2019 [March 8th, 2019]
- Procedures - Arizona Heart Rhythm Center - April 24th, 2019 [April 24th, 2019]
- Sudden death in young people: Heart problems often blamed ... - April 29th, 2019 [April 29th, 2019]
- abnormalities of cardiac conduction and cardiac rhythm ... - September 11th, 2019 [September 11th, 2019]
- Who is at risk for atrial fibrillation, or AFib, and why does it matter? - Yahoo Lifestyle - October 9th, 2019 [October 9th, 2019]
- Sanders Said He Had a Common Heart Procedure. So Why the Mystery? - The New York Times - October 9th, 2019 [October 9th, 2019]
- Media Advisory - Canadian Cardiovascular Congress gathers leading heart experts in Montreal to discuss latest research innovations - Canada NewsWire - October 24th, 2019 [October 24th, 2019]
- Why Did the Young Mother Have Searing Head Pain and a Racing Heart? - The New York Times - November 2nd, 2019 [November 2nd, 2019]
- Student Heart check scheduled for Dec. 14 at Fordson High School - Dearborn Press and Guide - November 22nd, 2019 [November 22nd, 2019]
- Neurometrix (NASDAQ:NURO) and Boston Scientific (NASDAQ:BSX) Head to Head Contrast - Riverton Roll - December 22nd, 2019 [December 22nd, 2019]
- Ask the Expert: What is ventricular tachycardia, and what treatment options are available? - The Daily Progress - December 22nd, 2019 [December 22nd, 2019]
- Beyond the Byline: Who really did steal the kishka? - Wilkes Barre Times-Leader - December 31st, 2019 [December 31st, 2019]
- Local leaders offer their Happy New Year wishes - Wilkes Barre Times-Leader - December 31st, 2019 [December 31st, 2019]
- Cardiologs raises $15m in Aleven-led Series A funding round - Medical Device Network - January 10th, 2020 [January 10th, 2020]
- Marion County Schools working to be "Heart Safe" certified - WDTV - January 10th, 2020 [January 10th, 2020]
- The Dangers of Weight Loss Supplements and Why You Should Avoid Them - One Green Planet - February 15th, 2020 [February 15th, 2020]
- Amish kids were dying mysteriously. Mayo scientists solved it. But can they treat it? - Minnesota Public Radio News - February 20th, 2020 [February 20th, 2020]
- UI doctors discover new genetic mutation that causes fatal heart arrhythmias - UI The Daily Iowan - February 22nd, 2020 [February 22nd, 2020]
- Here's Why You Shouldn't Worry About Apple Watch AFib Detection - The Mac Observer - February 27th, 2020 [February 27th, 2020]
- Team deciphers how myotonic dystrophy generates lethal heart dysfunctions - University of Illinois News - February 27th, 2020 [February 27th, 2020]
- Electrophysiology Market: Global Industry Valuation 2020| In Depth Analysis, Solution, Industry Influence By 2028 - Cole of Duty - May 23rd, 2020 [May 23rd, 2020]
- What you need to know about hydroxychloroquine - WTSP.com - May 23rd, 2020 [May 23rd, 2020]
- Malaria Drug Taken by Trump Is Tied to Increased Risk of Heart Problems and Death in New Study - The New York Times - May 23rd, 2020 [May 23rd, 2020]
- Research by Huami Shows Smart Wearable Device Big Data could assist with alerting new trends related to COVID-19 - Devdiscourse - May 24th, 2020 [May 24th, 2020]
- Dealing With Electrolyte Imbalances Including The Use Of Sports Drinks - Teton Gravity Research - May 28th, 2020 [May 28th, 2020]
- Abnormal EKG: What It Means and Treatment Options - May 28th, 2020 [May 28th, 2020]
- Abnormal Heart Rhythms: Types, Causes, Diagnosis, Treatment - May 28th, 2020 [May 28th, 2020]
- FDA pulls emergency use of hydroxychloroquine hyped by Trump for treating Covid-19, says it could pose risks - MEAWW - June 18th, 2020 [June 18th, 2020]
- Electrophysiology Market: Global Industry Valuation 2020| In Depth Analysis, Solution, Industry Influence By 2028 - 3rd Watch News - June 18th, 2020 [June 18th, 2020]
- Critically ill patients with COVID-19 at risk to develop heart rhythm disorders - Penn: Office of University Communications - June 29th, 2020 [June 29th, 2020]
- COVID-19 Patients in ICU 10 Times More Likely to Experience Heart Rhythm Disorders, Finds Study - HospiMedica - July 5th, 2020 [July 5th, 2020]
- Doctors Seeing Heart Inflammation In Young People With Coronavirus: Are These People At Risk? - CBS Pittsburgh - August 14th, 2020 [August 14th, 2020]
- EMS Treatment of Hyperkalemia - EMSWorld - September 7th, 2020 [September 7th, 2020]
- The virus and other diseases - The Indian Express - September 8th, 2020 [September 8th, 2020]
- Cardiac arrhythmia and COVID-19: Here are answers to some frequently-asked questions - The Indian Express - September 8th, 2020 [September 8th, 2020]
- COVID-19 and its effects on heart disease: How to create a system to safeguard patients during pandemic - Times Now - September 8th, 2020 [September 8th, 2020]
- The Wireless Ambulatory Telemetry Monitors market to ramify in unexplored territories in the next decade - KYT24 - October 23rd, 2020 [October 23rd, 2020]
- Health Pro: Cardiologist passionate about keeping your heart ticking - Florida Today - October 23rd, 2020 [October 23rd, 2020]
- What We Know About COVID-19 and Long-Term Heart Damage - Healthline - October 23rd, 2020 [October 23rd, 2020]
- COVID-19 can affect the heart - Science Magazine - October 23rd, 2020 [October 23rd, 2020]
- Researchers discover more effective treatment option for heart condition - OSU - The Lantern - October 23rd, 2020 [October 23rd, 2020]
- From breathlessness to brain fog, Indian doctors are now up against effects of long COVID - Firstpost - November 1st, 2020 [November 1st, 2020]
- Heart of the issue - The New Indian Express - December 8th, 2020 [December 8th, 2020]
- CB Scientific, Inc. (CBSC), Distributor Mango Wellness and My Cardia Thailand Well Positioned for Growth in 2021 - GlobeNewswire - December 28th, 2020 [December 28th, 2020]
- [Full text] Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance | TACG - Dove Medical Press - January 30th, 2021 [January 30th, 2021]
- Temporary Cardiac Pacing Wires & Leads Market Promising Growth Opportunities and Forecast 2018-2028 NeighborWebSJ - NeighborWebSJ - January 30th, 2021 [January 30th, 2021]
- Temporary Cardiac Pacing Leads Market Incredible Possibilities, Growth Analysis and Forecast To 2025 NeighborWebSJ - NeighborWebSJ - January 30th, 2021 [January 30th, 2021]
- COVID-19 Impact: Wide range of new, returning, or ongoing health problems - Free Press Journal - July 4th, 2021 [July 4th, 2021]
- Post-recovery, many COVID-19 patients report breathlessness, rapid heartbeats or palpitations, says expert - The Hindu - October 5th, 2021 [October 5th, 2021]
- Coronavirus and how it affects a person's heart - Goshen News - October 5th, 2021 [October 5th, 2021]
- Hackensack University Medical Center Cardiac Researcher Presented New Data about the Heart and COVID-19 and Other Key Topics at Heart Rhythm Society... - October 5th, 2021 [October 5th, 2021]
- New $17M Heart Rhythm Center will be added to Baptist Heart Hospital - Ponte Vedra Recorder - October 13th, 2021 [October 13th, 2021]
- My healthy wife died as I lay next to her I was making a cup of tea when my daughter realised... - The Sun - October 13th, 2021 [October 13th, 2021]
- What We Know About Cardiac Long-COVID Two Years Into the Pandemic - Diagnostic and Interventional Cardiology - January 26th, 2022 [January 26th, 2022]
- Monkeypox and the Heart: Acute Myocarditis Rare, With Good Outlook - TCTMD - September 4th, 2022 [September 4th, 2022]
- A Broken Heart After Witnessing a Dying Heart: A Case of Takotsubo Cardiomyopathy - Cureus - September 4th, 2022 [September 4th, 2022]